Get started
Award

ECS00000017

Funded outputs count: 15
Funder award ID: ECS00000017
OpenAlex ID: G6439120108
ERK5 inhibition triggers CDK6 proteasomal degradation and enhances palbociclib efficacy in cancer cells
2026 · Claudia Faundez-Vidiella, Ylenia Sfragano, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Longitudinal In Vivo Imaging at Single-Lesion Resolution Identifies Allele-Associated Response and Resistance Dynamics in EGFR-Mutant Lung Cancer
2026 · Eva Cabrera San Millan, Daniele Panetta, et al. · International Journal of Molecular Sciences
Plasma Gelation as an Overlooked Determinant of Transfection Efficiency in Protein Corona‐Coated Lipid Nanoparticles: Implications for In Vitro–In Vivo Translation
2026 · Serena Renzi, Luca Digiacomo, et al. · Advanced Healthcare Materials · 1
PDF
Targeting the LIPH-CD36 axis potentiates CDK4/6 inhibition in ER+ breast cancer
2026 · Andrea Morandi, Nicla Lorito, et al. · Research Square
PDF
A multidisciplinary experimental and methodological investigation of electron and proton minibeams in the framework of the INFN MIRO project
2026 · Francesco Romano, Francesca Cella Zanacchi, et al. · Medical Physics
R-Ras coordinates reciprocal activation of ERK5 and ERK1/2 under single pathway inhibition in melanoma
2026 · Ignazia Tusa, Cosimo Mazzei, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLC
2026 · Paolo Armanetti, Eva Cabrera San Millan, et al. · Cell Death and Disease · 1
PDF
Amino acid metabolism at the senescence–cancer interface
2026 · Giulia Lori, Caterina Mancini, et al. · Trends in cancer
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells
2026 · Giulia Lori, Caterina Mancini, et al. · Cells · 1
PDF
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability
2026 · Sara Franceschi, Mariangela Morelli, et al. · Cell Death Discovery
PDF
ProTide-enabled antibody-drug conjugates: A novel platform for the targeted delivery of phosphorylated drugs
2025 · Sofia Siciliano, Clizia Bernardi, et al. · Bioorganic Chemistry · 3
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes
2025 · Marina Serra, Alfredo Smiriglia, et al. · Cell Death and Disease
PDF
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer
2025 · Alessia Corrado, Nicla Lorito, et al. · Breast Cancer Research · 12
PDF
Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with “Clickable” Doxorubicin
2024 · Irene Lepori, Marta Roncetti, et al. · ACS Chemical Biology · 15
PDF
Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells
2023 · Claudia Duranti, Jessica Iorio, et al. · Life Science Alliance · 8
PDF
Year
Topic